Periodic Reporting for period 2 - MELGEN (MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival)

The MELGEN Early Training Network (ETN) and Consortium was designed as an environment for long-term, collaborative, cancer genetics research with the ultimate aim of improving precision (personalised) medicine. MELGEN has worked primarily to understand survival from melanoma...